Clinical Study

Gog0238- A Randomized Trial Of Pelvic Irradiation With Or Without Concurrent Weekly Cisplatin In Patients With Pelvic-Only Recurrence Of Carcinoma Of The Uterine Corpus

Posted Date: May 15, 2019

  • Investigator: Thomas Herzog
  • Specialties: Cancer, Oncology
  • Type of Study: Drug

The main purpose of this study is to compare radiation therapy in combination with weekly treatment with the chemotherapy drug cisplatin to the standard treatment for this type of cancer to see which is better. The standard treatment for patients with your type of cancer is radiation therapy alone.

Criteria:

To Be Eligible: Patient Must Be 18 Years Of Age Or Older, Patient Must Have Had A Complete Hysterectomy And Bilateral Salpingo-Oophorectomy, Patients Must Have Estimated Survival Greater Than 3 Months, No Previous Irradiation Or Severe Infection, No History Of Other Invasive Malignancies

Keywords:

Uterine Cancer, Recurrent, Uterine Cancer

For More Information:

Uc Cancer Institute
513-584-7698
cancer@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.